Stay updated on LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial page.

Latest updates to the LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial page
- Check5 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check12 days agoChange DetectedA sitewide banner announces NIH’s website transition and says “Super Intelligence” is replacing “Artificial Intelligence” in some NIH content.SummaryDifference1%

- Check19 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the study record page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov page.SummaryDifference0.2%

- Check47 days agoChange DetectedThe study page now displays a 403 Forbidden error with minimal navigation, replacing the previous study content and indicating that the page is currently unavailable.SummaryDifference20%

- Check68 days agoChange DetectedPage revision updated from v3.6.5 to v3.6.6, indicating a new version tag. This appears to be a metadata change with no visible changes to page content or functionality.SummaryDifference0.1%

Stay in the know with updates to LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial page.